Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 47
15
Diseases
128
Unique genes
0.116
Avg. similarity score
Childhood absence epilepsy
Most-connected disease (7 links)
Disease
Searched: Myoclonic epilepsy
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Myoclonic epilepsy
Childhood absence epilepsy
Dravet syndrome
Absence epilepsy
Lennox-gastaut syndrome
Febrile convulsion
Generalized epilepsy with febrile seizures plus
Rolandic epilepsy
Ataxia
Idiopathic generalized epilepsy
Synovial disorder
Conn syndrome
Female restricted epilepsy with intellectual disability
Juvenile absence epilepsy
Cranio-cervical dystonia
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Childhood absence epilepsy | 7 | 7 | 10 |
| Dravet syndrome | 7 | 7 | 8 |
| Absence epilepsy | 6 | 6 | 7 |
| Lennox-gastaut syndrome | 6 | 6 | 12 |
| Febrile convulsion | 5 | 5 | 22 |
| Generalized epilepsy with febrile seizures plus | 4 | 4 | 16 |
| Rolandic epilepsy | 4 | 4 | 47 |
| Ataxia | 3 | 3 | 21 |
| Idiopathic generalized epilepsy | 3 | 3 | 12 |
| Myoclonic epilepsy | 3 | 3 | 24 |
| Synovial disorder | 3 | 3 | 6 |
| Conn syndrome | 2 | 2 | 1 |
| Female restricted epilepsy with intellectual disability | 2 | 2 | 1 |
| Juvenile absence epilepsy | 2 | 2 | 1 |
| Cranio-cervical dystonia | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| GABRG2 | 6 / 15 | Childhood absence epilepsy, Dravet syndrome, Febrile convulsion, Generalized epilepsy with febrile seizures plus and 2 more |
| SCN1A | 6 / 15 | Dravet syndrome, Febrile convulsion, Generalized epilepsy with febrile seizures plus, Lennox-gastaut syndrome and 2 more |
| GABRA1 | 5 / 15 | Ataxia, Childhood absence epilepsy, Dravet syndrome, Idiopathic generalized epilepsy and 1 more |
| SCN1B | 5 / 15 | Childhood absence epilepsy, Dravet syndrome, Febrile convulsion, Generalized epilepsy with febrile seizures plus and 1 more |
| SCN2A | 5 / 15 | Dravet syndrome, Febrile convulsion, Generalized epilepsy with febrile seizures plus, Lennox-gastaut syndrome and 1 more |
| GABRB3 | 4 / 15 | Absence epilepsy, Childhood absence epilepsy, Lennox-gastaut syndrome, Synovial disorder |
| SCN9A | 4 / 15 | Dravet syndrome, Febrile convulsion, Generalized epilepsy with febrile seizures plus, Rolandic epilepsy |
| SLC2A1 | 4 / 15 | Ataxia, Childhood absence epilepsy, Idiopathic generalized epilepsy, Rolandic epilepsy |
| CACNA1A | 3 / 15 | Absence epilepsy, Ataxia, Lennox-gastaut syndrome |
| CACNA1H | 3 / 15 | Absence epilepsy, Childhood absence epilepsy, Conn syndrome |
| CACNB4 | 3 / 15 | Ataxia, Idiopathic generalized epilepsy, Myoclonic epilepsy |
| CPA6 | 3 / 15 | Febrile convulsion, Generalized epilepsy with febrile seizures plus, Rolandic epilepsy |
| EFHC1 | 3 / 15 | Absence epilepsy, Juvenile absence epilepsy, Myoclonic epilepsy |
| GABRD | 3 / 15 | Generalized epilepsy with febrile seizures plus, Idiopathic generalized epilepsy, Myoclonic epilepsy |
| HCN1 | 3 / 15 | Ataxia, Febrile convulsion, Generalized epilepsy with febrile seizures plus |
| JRK | 3 / 15 | Absence epilepsy, Childhood absence epilepsy, Myoclonic epilepsy |
| PCDH19 | 3 / 15 | Dravet syndrome, Female restricted epilepsy with intellectual disability, Rolandic epilepsy |
| ADGRV1 | 2 / 15 | Febrile convulsion, Generalized epilepsy with febrile seizures plus |
| ANO3 | 2 / 15 | Cranio-cervical dystonia, Febrile convulsion |
| CACNA2D2 | 2 / 15 | Absence epilepsy, Ataxia |
| CHD2 | 2 / 15 | Lennox-gastaut syndrome, Rolandic epilepsy |
| CLCN2 | 2 / 15 | Idiopathic generalized epilepsy, Myoclonic epilepsy |
| HCN2 | 2 / 15 | Febrile convulsion, Idiopathic generalized epilepsy |
| KCNQ3 | 2 / 15 | Myoclonic epilepsy, Rolandic epilepsy |
| PRICKLE2 | 2 / 15 | Myoclonic epilepsy, Rolandic epilepsy |
| RELN | 2 / 15 | Generalized epilepsy with febrile seizures plus, Rolandic epilepsy |
| SCN8A | 2 / 15 | Ataxia, Febrile convulsion |
| STX1B | 2 / 15 | Febrile convulsion, Generalized epilepsy with febrile seizures plus |
| STXBP1 | 2 / 15 | Dravet syndrome, Myoclonic epilepsy |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Nicotine addiction | KEGG | 13 / 41 | 29.8× | 1.68e-16 | 7.14e-14 ✓ sig. |
| GABA receptor activation | Reactome | 8 / 16 | 46.9× | 1.60e-12 | 3.32e-10 ✓ sig. |
| GABAergic synapse | KEGG | 13 / 89 | 13.7× | 8.74e-12 | 1.61e-9 ✓ sig. |
| Phase 0 - rapid depolarisation | Reactome | 9 / 44 | 19.2× | 6.91e-10 | 8.42e-8 ✓ sig. |
| Morphine addiction | KEGG | 11 / 91 | 11.3× | 3.00e-9 | 3.14e-7 ✓ sig. |
| Retrograde endocannabinoid signaling | KEGG | 13 / 149 | 8.2× | 6.06e-9 | 5.97e-7 ✓ sig. |
| Taste transduction | KEGG | 10 / 86 | 10.9× | 2.37e-8 | 1.96e-6 ✓ sig. |
| Neuroactive ligand-receptor interaction | KEGG | 16 / 370 | 4.1× | 1.92e-6 | 9.14e-5 ✓ sig. |
| HCN channels | Reactome | 3 / 4 | 70.4× | 4.69e-6 | 1.93e-4 ✓ sig. |
| Presynaptic depolarization and calcium channel opening | Reactome | 4 / 12 | 31.3× | 5.70e-6 | 2.25e-4 ✓ sig. |
| Synaptic vesicle cycle | KEGG | 7 / 79 | 8.3× | 2.03e-5 | 6.39e-4 ✓ sig. |
| Highly calcium permeable nicotinic acetylcholine receptors | Reactome | 3 / 9 | 31.3× | 9.48e-5 | 2.22e-3 ✓ sig. |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | Reactome | 3 / 12 | 23.5× | 2.42e-4 | 4.66e-3 ✓ sig. |
| Regulation of insulin secretion | Reactome | 3 / 16 | 17.6× | 5.98e-4 | 9.49e-3 ✓ sig. |
| Adipocytokine signaling pathway | KEGG | 5 / 70 | 6.7× | 8.84e-4 | 1.27e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| monoatomic ion transmembrane transport | GO:0034220 | 33 / 404 | 11.9× | 2.03e-26 | 7.46e-23 ✓ sig. |
| monoatomic ion transport | GO:0006811 | 37 / 667 | 8.1× | 1.03e-23 | 2.86e-20 ✓ sig. |
| chloride transmembrane transport | GO:1902476 | 16 / 114 | 20.5× | 6.58e-17 | 6.42e-14 ✓ sig. |
| regulation of postsynaptic membrane potential | GO:0060078 | 13 / 59 | 32.2× | 1.21e-16 | 1.13e-13 ✓ sig. |
| gamma-aminobutyric acid signaling pathway | GO:0007214 | 10 / 30 | 48.7× | 4.25e-15 | 3.01e-12 ✓ sig. |
| inhibitory synapse assembly | GO:1904862 | 9 / 25 | 52.6× | 4.65e-14 | 2.73e-11 ✓ sig. |
| regulation of membrane potential | GO:0042391 | 12 / 85 | 20.6× | 5.44e-13 | 2.62e-10 ✓ sig. |
| synaptic transmission, GABAergic | GO:0051932 | 9 / 35 | 37.5× | 1.52e-12 | 6.79e-10 ✓ sig. |
| chemical synaptic transmission | GO:0007268 | 16 / 236 | 9.9× | 6.70e-12 | 2.58e-9 ✓ sig. |
| chloride transport | GO:0006821 | 11 / 81 | 19.8× | 8.13e-12 | 3.06e-9 ✓ sig. |
| sodium ion transmembrane transport | GO:0035725 | 12 / 134 | 13.1× | 1.31e-10 | 3.74e-8 ✓ sig. |
| neuronal action potential | GO:0019228 | 7 / 34 | 30.1× | 2.77e-9 | 5.51e-7 ✓ sig. |
| transmembrane transport | GO:0055085 | 18 / 557 | 4.7× | 4.76e-8 | 6.56e-6 ✓ sig. |
| sodium ion transport | GO:0006814 | 10 / 144 | 10.1× | 5.64e-8 | 7.54e-6 ✓ sig. |
| positive regulation of excitatory postsynaptic potential | GO:2000463 | 6 / 32 | 27.4× | 7.19e-8 | 9.27e-6 ✓ sig. |